Prenetics Global Limited (PRENW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 17Jul 22Jul 29Aug 6Aug 11Aug 18Aug 26Sep 1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.7x

Market Cap

$200959.57

MomentumView details →

1D Return

+34.91%

YTD Return

−52.01%

RSI (14)

52.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.7x

Market Cap

$200959.57

RSI (14)

52.8

MomentumView details →

1D Return

+34.91%

YTD Return

−52.01%

ProfitabilityView details →

Gross Margin

62.61%

Net Margin

−47.43%

EBITDA Margin

−43.85%

ROE (TTM)

−72.69%

ROA (TTM)

−44.00%

Asset Turnover

0.87x

GrowthView details →

Revenue YoY

+167.67%

EPS YoY

−7.49%

FCF YoY

—

Revenue CAGR 3Y

+91.46%

EPS CAGR 3Y

+26.37%

EBITDA YoY

−8.32%

EarningsView details →

EPS (Actual)

−$0.52

EPS Surprise

38.10%

Beats (12Q)

1/12

Next Q EPS Est

−$0.77

Avg Surprise (4Q)

−17.40%

Rev Surprise

−6.74%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

4.04x

Quick Ratio

3.66x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

142.56M

Net Income (TTM)

−67.61M

Op. CF (TTM)

−49.39M

Next earningsNov 5, 2026 →

Latest newsMore news →

No recent news for PRENW.

Similar companies

bioAffinity Technologies, Inc.BIAFW Inotiv, Inc.NOTV Aspira Women's Health Inc.AWH iSpecimen Inc.ISPC BioNexus Gene Lab Corp.BGLC Intelligent Bio Solutions Inc.INBS Find similar companies →

Latest newsMore news →

No recent news for PRENW.